RECURRENT MENINGIOMA
Clinical trials for RECURRENT MENINGIOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT MENINGIOMA trials appear
Sign up with your email to follow new studies for RECURRENT MENINGIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Radioactive drug trial offers new hope for Tough-to-Treat brain tumors
Disease control Recruiting nowThis study is testing a radioactive drug called Lutathera for patients with a type of brain tumor called meningioma that cannot be removed by surgery and has continued to grow after radiation treatment. The drug is given through an IV and is designed to find and kill tumor cells.…
Matched conditions: RECURRENT MENINGIOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Precision radiation therapy trial offers new hope for tough brain tumors
Disease control Recruiting nowThis trial is testing a new, targeted radiation treatment for adults with recurrent meningioma, a type of brain tumor that has returned after surgery and radiation. The treatment uses a radioactive drug that seeks out and delivers radiation directly to tumor cells. Researchers wi…
Matched conditions: RECURRENT MENINGIOMA
Phase: PHASE2 • Sponsor: European Organisation for Research and Treatment of Cancer - EORTC • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
Radioactive drug targets recurrent brain tumors in new trial
Disease control Recruiting nowThis early-stage trial is testing a radioactive drug called RYZ101 for adults with recurrent or worsening meningioma brain tumors. The drug is designed to seek out and deliver radiation directly to tumor cells. Researchers aim to find a safe dose and see if it can help control tu…
Matched conditions: RECURRENT MENINGIOMA
Phase: PHASE1, PHASE2 • Sponsor: Joshua Palmer • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Personalized medicine attack on recurrent brain tumors
Disease control Recruiting nowThis study is testing four different targeted drugs for adults with meningioma brain tumors that are growing or have come back after treatment. The specific drug a patient receives is chosen based on the unique genetic mutations found in their tumor. The main goal is to see if th…
Matched conditions: RECURRENT MENINGIOMA
Phase: PHASE2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Mar 11, 2026 14:52 UTC